KORU Medical Systems (KRMD) vs Nyxoah SA (NYXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
KORU Medical Systems (KRMD) has outperformed Nyxoah SA (NYXH) over the past year, losing 28.4% versus a loss of 77.9%. Over five years, KRMD leads with a +4.5% price change compared with -94.7% for NYXH. Nyxoah SA is the larger company by market cap ($138.5 million vs $136.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRMD | NYXH |
|---|---|---|
| Share price | $2.96 | $1.36 |
| Market cap | $135.96M | $138.50M |
| 1-day change | -1.33% | +0.74% |
| YTD return | -48.36% | -70.65% |
| 1-year return | -28.40% | -77.87% |
| 5-year return | +4.53% | -94.71% |
| Forward P/E | 84.57 | — |
| EPS (TTM) | $-0.04 | $-2.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.61 | $6.88 |
| 52-week low | $2.86 | $1.26 |
| Distance from 52-week high | -55.21% | -80.22% |
| Analyst consensus | none | none |
| Avg. price target upside | +111.15% | +208.82% |
| Average volume | 235.20K | 275.85K |
| Shares outstanding | 45.93M | 101.84M |
| Employees | 73 | 153 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KRMD has outperformed NYXH by 49.5 percentage points over the past year.
About KORU Medical Systems
KRMD stock →KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Health Care · Medical/Dental Instruments · 73 employees
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
KRMD vs NYXH FAQ
Which is bigger, KORU Medical Systems or Nyxoah SA?
Nyxoah SA (NYXH) is larger, with a market capitalization of $138.50M compared with $135.96M for KORU Medical Systems (KRMD).
Which stock has performed better over the past year, KRMD or NYXH?
KRMD returned -28.40% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are KORU Medical Systems and Nyxoah SA in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.